Helen Cox

19.3k total citations · 2 hit papers
163 papers, 6.9k citations indexed

About

Helen Cox is a scholar working on Infectious Diseases, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Helen Cox has authored 163 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Infectious Diseases, 80 papers in Epidemiology and 32 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Helen Cox's work include Tuberculosis Research and Epidemiology (92 papers), Pneumocystis jirovecii pneumonia detection and treatment (37 papers) and Pneumonia and Respiratory Infections (31 papers). Helen Cox is often cited by papers focused on Tuberculosis Research and Epidemiology (92 papers), Pneumocystis jirovecii pneumonia detection and treatment (37 papers) and Pneumonia and Respiratory Infections (31 papers). Helen Cox collaborates with scholars based in South Africa, Australia and United States. Helen Cox's co-authors include Murray Esler, Garry Jennings, Jennifer Furin, Gavin Lambert, Madhukar Pai, Andrea Turner, Graeme Eisenhofer, Nathan Ford, David M. Kaye and Stefan Niemann and has published in prestigious journals such as The Lancet, Circulation and Nature Communications.

In The Last Decade

Helen Cox

158 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tuberculosis

2019 562 citations Jennifer Furin, Helen Cox et al. profile →
Drug-resistant tuberculosis: a persistent global health concern

2024 70 citations Helen Cox, Jennifer Furin et al. profile →

Peers

Countries citing papers authored by Helen Cox

Since Specialization

Citations

This map shows the geographic impact of Helen Cox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Cox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Cox more than expected).

Fields of papers citing papers by Helen Cox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Cox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Cox. The network helps show where Helen Cox may publish in the future.

Co-authorship network of co-authors of Helen Cox

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Cox. A scholar is included among the top collaborators of Helen Cox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Cox. Helen Cox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Diagnostic accuracy of a commercial AI digital stethoscope for diagnosis of TB 2025 ·PubMed ·Helen Cox, (unknown), Lydia Nakiyingi, (unknown), (unknown), (unknown), Nchimunya Hapeela, Guillermo Romero, (unknown), Nguyễn Văn Hùng, (unknown), Adam Penn‐Nicholson, Susan E. Dorman	0
2	Targeted deep sequencing of mycobacteria species from extrapulmonary sites not identified by routine line probe assays: A retrospective laboratory analysis of stored clinical cultures 2024 ·IJID Regions ·(unknown), (unknown), (unknown), (unknown), Yonas Ghebrekristos, Tanya J. Kerr, Michele A. Miller, Aliasgar Esmail, Helen Cox, Robin M. Warren, Giovanni Ghielmetti, Wynand J. Goosen	1
3	HIV co-infection is associated with reduced Mycobacterium tuberculosis transmissibility in sub-Saharan Africa 2024 ·PLoS Pathogens ·Etthel M. Windels, Eddie M. Wampande, Moses Joloba, W. Henry Boom, Galo A. Goig, Helen Cox, Jerry Hella, Sònia Borrell, Sébastien Gagneux, Daniela Brites, Tanja Stadler	4
4	Association between HIV and acquisition of rifamycin resistance with first-line TB treatment: a systematic review and meta-analysis 2024 ·BMC Infectious Diseases ·Nesbert Zinyakatira, Nathan Ford, Helen Cox	2
5	A promising potential: Using the right to enjoy the benefits of scientific progress to advance public health in Africa 2023 ·African Human Rights Law Journal ·(unknown), Fons Coomans, Helen Cox, Leslie London	1
6	Characterisation of patients referred to a tertiary-level inherited cardiac condition clinic with suspected arrhythmogenic right ventricular cardiomyopathy (ARVC) 2023 ·BMC Cardiovascular Disorders ·(unknown), Tania Kew, Shanat Baig, Helen Cox, (unknown), Bode Ensam, Manish Kalla, Richard P. Steeds, Larissa Fabritz	1
7	Effect of compensatory evolution in the emergence and transmission of rifampicin-resistant Mycobacterium tuberculosis in Cape Town, South Africa: a genomic epidemiology study 2023 ·The Lancet Microbe ·Galo A. Goig, Fabrizio Menardo, (unknown), Anzaan Dippenaar, Elizabeth M. Streicher, Johnny Daniels, Anja Reuter, Sònia Borrell, Miriam Reinhard, (unknown), Christian Beisel, Robin M. Warren, Helen Cox, Sébastien Gagneux	20
8	Transcontinental spread and evolution of Mycobacterium tuberculosis W148 European/Russian clade toward extensively drug resistant tuberculosis 2022 ·Nature Communications ·Matthias Merker, Jean‐Philippe Rasigade, Maxime Barbier, Helen Cox, Silke Feuerriegel, Thomas A. Kohl, Egor Shitikov, (unknown), Cyril Gaudin, Rudy Antoine, Roland Diel, Sònia Borrell, Sébastien Gagneux, Vladyslav Nikolayevskyy, Sönke Andres, Valeriu Crudu, Philip Supply, Stefan Niemann, Thierry Wirth	38
9	Evaluation of Nanopore sequencing for Mycobacterium tuberculosis drug susceptibility testing and outbreak investigation: a genomic analysis 2022 ·The Lancet Microbe ·Michael B. Hall, Marie Sylvianne Rabodoarivelo, Anastasia Koch, Anzaan Dippenaar, Sophie George, Melanie Grobbelaar, Robin M. Warren, A Sarah Walker, Helen Cox, Sébastien Gagneux, Derrick W. Crook, Tim Peto, Niaina Rakotosamimanana, Simon Grandjean Lapierre, Zamin Iqbal	47
10	Novel compound heterozygous TTN variants as a cause of severe neonatal congenital contracture syndrome without cardiac involvement diagnosed with rapid trio exome sequencing 2021 ·Neuromuscular Disorders ·Helen McDermott, Amy Henderson, Hannah K. Robinson, Richard Heaver, (unknown), Helen Cox, Swati Naik	7
11	Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study 2018 ·The Lancet Infectious Diseases ·Gabriella Ferlazzo, Erika Mohr-Holland, Chinmay Laxmeshwar, Catherine Hewison, Jennifer Hughes, Sylvie Jonckheere, Naira Khachatryan, (unknown), (unknown), Amir Shroufi, Stobdan Kalon, Helen Cox, Jennifer Furin, Petros Isaakidis	91
12	Carpe diem (‘Seize the day’): Building on the findings of the 2015 World Health Organization evaluation of the multidrug-resistant tuberculosis (MDR-TB) programme to make the most of shortened MDR-TB treatment in South Africa 2017 ·SHILAP Revista de lepidopterología ·Marian Loveday, Helen Cox	1
13	Cost per patient of treatment for rifampicin‐resistant tuberculosis in a community‐based programme in Khayelitsha, South Africa 2015 ·Tropical Medicine & International Health ·Helen Cox, Lebogang Ramma, Lynne Wilkinson, Virginia De Azevedo, Edina Sinanovic	30
14	The scourge of tuberculosis and anti-tuberculosis drug resistance in Eastern Europe 2014 ·Public Health Action ·Helen Cox, Nathan Ford	3
15	Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes 2012 ·European Respiratory Journal ·Dennis Falzon, Neel R. Gandhi, Giovanni Battista Migliori, Giovanni Sotgiu, Helen Cox, Timothy H. Holtz, Maria-Graciela Hollm-Delgado, Salmaan Keshavjee, Kathryn DeRiemer, Rosella Centis, Lia D’Ambrosio, Christoph Lange, Melissa Bauer, Dick Menzies	259
16	Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis 2012 ·Journal of Antimicrobial Chemotherapy ·(unknown), Grania Brigden, Helen Cox, Zara Shubber, Graham Cooke, Nathan Ford	100
17	Decentralised care for the management of child contacts of multidrug-resistant tuberculosis 2012 ·Public Health Action ·James A. Seddon, Anneke C. Hesseling, Rory Dunbar, Helen Cox, Jennifer Hughes, Katherine Fielding, Peter Godfrey‐Faussett, H. Simon Schaaf	1
18	Genomic Diversity among Drug Sensitive and Multidrug Resistant Isolates of Mycobacterium tuberculosis with Identical DNA Fingerprints 2009 ·PLoS ONE ·Stefan Niemann, Claudio U. Köser, Sébastien Gagneux, (unknown), Susanne Homolka, (unknown), Richard J. Carter, R. Keira Cheetham, Anthony J. Cox, Niall Gormley, (unknown), Lisa Murray, Roberto Rigatti, Vincent P. Smith, (unknown), Helen Cox, (unknown), John A. C. Archer	113
19	Tuberculosis Recurrence and Mortality after Successful Treatment: Impact of Drug Resistance 2006 ·PLoS Medicine ·Helen Cox, (unknown), (unknown), (unknown), (unknown), Graham Byrnes, Christine Stone, Stefan Niemann, Sabine Rüsch–Gerdes, Lucie Blok, (unknown)	111
20	Sympathetic Nervous Activity and the Thermic Effect of Food in Humans 1997 ·Advances in pharmacology ·Mário Vaz, Murray Esler, Helen Cox, Garry Jennings, David M. Kaye, Andrea Turner	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact